Skip to main content

Table 1 Patients characteristic

From: KAT3B-p300 and H3AcK18/H3AcK14 levels are prognostic markers for kidney ccRCC tumor aggressiveness and target of KAT inhibitor CPTH2

 

Number of cases

Age ± SD

(range)

Tumor grade [41]

(WHO-UISP2011)

Tumor stage [32]

pTNM

Cases

70

64.21 ± 11.24

(29–91)

G1 = 20

G2 = 26

G3 = 24

Stage 1 = 35Stage 2 = 16Stage 3 = 16Stage 4 = 1

Male

46

64.63 ± 11,84

(29–91)

G1 = 15

G2 = 16

G3 = 15

Stage I = 23Stage II = 9Stage III =12Stage IV = 1

Female

24

63.42 ± 10.18

(45–79)

G1 = 5

G2 = 10

G3 = 9

Stage I = 12Stage II = 7Stage III = 4Stage IV = 0